Profile data is unavailable for this security.
About the company
Hofseth Biocare ASA is a Norway-based biotech company that offers ingredients and finished products for humans and animals. The Company’s business is development, manufacturing, marketing and sale of marine ingredients such as oil, calcium and protein products. Its main products are Salmon protein hydrolysate (ProGo), which is a protein for sports, endurance, and recovery powders; Fresh, all-natural salmon oil (OmeGo) that has a full spectrum of omega fatty acids, including EPA, DHA and DPA, totaling 21 different fatty acids; Calcium bone powder (CalGo) is a natural marine collagenic bone powder and CollaGo is a Collagen Peptide powder optimised to improve the beauty of hair, skin and nails. Hofseth BioCare's headquarters are in Aalesund with branches in Oslo, Chicago, Mumbai, Tokyo and Menlo Park, California.
- Revenue in NOK (TTM)249.16m
- Net income in NOK-130.32m
- Incorporated2009
- Employees65.00
- LocationHofseth Biocare ASAKipervikgata 13ALESUND 6003NorwayNOR
- Phone+47 73102200
- Fax+47 66765562
- Websitehttps://hofsethbiocare.com
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| New Nordic Healthbrands AB | 617.66m | 8.67m | 112.06m | 77.00 | 12.92 | 1.02 | 9.52 | 0.1814 | 1.30 | 1.30 | 92.88 | 16.54 | 2.32 | 1.93 | 6.08 | 7,991,570.00 | 3.26 | 1.94 | 7.88 | 3.98 | 64.29 | 66.25 | 1.40 | 0.8811 | 0.8251 | 5.19 | 0.2753 | 76.22 | 3.08 | 3.99 | -24.30 | -- | 21.35 | -- |
| Simris Group AB | 2.47m | -31.38m | 216.41m | 6.00 | -- | -- | -- | 87.61 | -0.0638 | -0.0638 | 0.0046 | -0.0228 | 0.0151 | 1.16 | 2.43 | 287,625.00 | -19.20 | -26.85 | -23.51 | -30.61 | 69.97 | -11.89 | -1,270.27 | -765.74 | 0.1508 | -32.84 | -- | -- | -33.62 | 10.64 | 7.24 | -- | 11.48 | -- |
| Fodelia Oyj | -1.14tn | -1.14tn | 474.33m | 131.00 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 1.78 | -- | 2.76 | -- | 46.93 | -- | 0.9629 | -- | -- | -- | 121.99 | 1.73 | 18.86 | 310.19 | 2.75 | -23.29 | -- |
| Hofseth Biocare ASA | 249.16m | -130.32m | 533.36m | 65.00 | -- | -- | -- | 2.14 | -0.3172 | -0.3172 | 0.6064 | -0.0661 | 0.6586 | 2.25 | 9.80 | -- | -34.45 | -30.01 | -70.77 | -50.05 | 38.13 | 24.22 | -52.30 | -81.95 | 0.4723 | -9.02 | 1.11 | -- | 32.09 | 30.59 | -17.45 | -- | -27.30 | -- |
| Skane mollan AB | 253.77m | 11.92m | 651.81m | 27.00 | 54.70 | 3.84 | 33.55 | 2.57 | 1.01 | 1.01 | 21.49 | 14.39 | 1.24 | -- | 10.93 | 8,755,556.00 | 5.81 | 8.84 | 6.46 | 9.96 | 16.50 | 18.84 | 4.70 | 6.73 | -- | -- | -- | 90.85 | -10.81 | 3.62 | -31.41 | -11.37 | -- | 3.13 |
| Premium Snacks Nordic AB | 568.56m | 23.29m | 727.12m | 70.00 | 31.06 | 8.29 | 20.44 | 1.28 | 1.60 | 1.60 | 39.45 | 6.01 | 2.78 | 7.26 | 11.43 | 7,566,357.00 | 11.38 | 1.01 | 22.62 | 1.95 | 41.23 | 40.65 | 4.10 | 0.4417 | 0.6536 | 13.15 | 0.3351 | 33.61 | 22.43 | 7.43 | 938.64 | 55.64 | -3.02 | -- |
| Apetit Oyj | 1.90bn | 62.76m | 1.01bn | 310.00 | 15.89 | 0.8552 | 7.08 | 0.5315 | 0.881 | 0.881 | 26.76 | 16.37 | 1.36 | 3.56 | 26.00 | 453,406.00 | 4.51 | 3.84 | 5.12 | 5.28 | 34.62 | 23.55 | 3.31 | 2.45 | 1.18 | 8.33 | 0.0678 | 67.94 | -7.35 | -11.35 | -12.37 | -- | -5.03 | 10.76 |
| Cheffelo AB (publ) | 1.25bn | 56.21m | 1.50bn | 401.00 | 26.89 | 3.29 | 14.64 | 1.20 | 3.98 | 3.98 | 88.76 | 32.49 | 1.57 | 50.01 | 44.06 | 2,909,549.00 | 7.09 | -0.4429 | 9.44 | -0.5595 | 42.52 | 40.27 | 4.51 | -0.317 | 0.9616 | 59.93 | 0.1819 | -- | 5.85 | -0.5103 | 67.98 | -- | 0.2807 | -- |
| Midsona AB | 3.90bn | 10.73m | 1.63bn | 697.00 | 145.98 | 0.5206 | 6.65 | 0.4194 | 0.0719 | 0.0719 | 25.04 | 20.17 | 0.8134 | 4.44 | 10.71 | 5,208,035.00 | 0.2241 | -1.69 | 0.2609 | -1.98 | 28.51 | 26.33 | 0.2755 | -2.17 | 1.17 | 5.32 | 0.1733 | -- | -2.60 | -0.4297 | -78.72 | -43.65 | -17.32 | -29.35 |
| HKFoods Oyj | 11.33bn | 0.00 | 1.72bn | 3.02k | 6.89 | 0.9575 | 3.65 | 0.1518 | 0.257 | -0.1812 | 15.00 | 1.85 | 1.82 | 12.48 | 13.82 | 331,100.00 | 1.39 | -0.616 | 2.07 | -0.919 | 16.08 | 28.29 | 0.7651 | -0.4304 | 0.7178 | 2.21 | 0.5051 | -- | 7.37 | -10.50 | 59.62 | -- | -0.637 | -- |
| Dellia Group ASA | -100.00bn | -100.00bn | 2.29bn | 19.00 | -- | 10.93 | -- | -- | -- | -- | -- | 38.33 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 1.39 | -- | 0.3034 | -- | 151.16 | -- | -21.33 | -- | -- | -- |
Data as of Feb 10 2026. Currency figures normalised to Hofseth Biocare ASA's reporting currency: Norwegian Krone NOK
16.85%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Bonafide Wealth Management AG (Liechtenstein)as of 19 Feb 2025 | 66.55m | 16.85% |
| SSgA Funds Management, Inc.as of 08 Jan 2026 | 8.27k | 0.00% |
| DNB Asset Management ASas of 28 Nov 2025 | 0.00 | 0.00% |
Data from 31 Dec 2024 - 31 Dec 2025Source: FactSet Research Systems Inc.
